IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Chelsea Therapeutics Intl LTD CVR

CUSIP: 163428CVR | 1 institutional holders

Quarters

Q2 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2014

Vanguard Group Inc2,568,392
0.0% of portfolio›$283
StyleTurnoverLocationFiled
Vanguard Group Inc
2,568,392$2830.0%N/AN/AValley Forge, PA2014-08-11